Company / Free Cash Flow per Share
Organon & Co. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.09
FY2025
5-year range
$2.09 / $11.55
FY2021-FY2025
Trend
-30.2%
vs FY2024
Sector context
#34 of 192
Health Care
What the data says
Organon & Co.'s free cash flow per share of $2.09 is higher than 82% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $2.09 in FY2025 to $11.55 in FY2019.
Based on SEC 10-K filings.
2.09 in FY2025 with a 5-year CAGR of -23.6%. Top quartile in the Health Care sector.
Declined from $2.15 to $2.09 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -7.2%
- 5-Year CAGR
- -23.6%
- 10-Year CAGR
- -
Sector benchmark
-37.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 30.2% year-over-year.
- Ranks #34 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.09 | -30.2% |
| FY2024 | $2.99 | +38.7% |
| FY2023 | $2.15 | -17.5% |
| FY2022 | $2.61 | -77.4% |
| FY2021 | $11.55 | +44.3% |
| FY2020 | $8.00 | -30.7% |
| FY2019 | $11.55 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026